Intellia Therapeutics, Inc.NTLANASDAQ
Loading
Interest Income Over TimeContracting
Percentile Rank82
3Y CAGR+50.6%
5Y CAGR+65.5%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+50.6%/yr
vs +11.5%/yr prior
5Y CAGR
+65.5%/yr
Recent deceleration
Acceleration
+39.1pp
Accelerating
Percentile
P82
Within normal range
vs 5Y Ago
12.4x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$29.20M-38.9%
2024$47.81M-4.1%
2023$49.83M+483.4%
2022$8.54M+565.8%
2021$1.28M-45.5%
2020$2.35M-65.6%
2019$6.83M+23.7%
2018$5.53M+174.7%
2017$2.01M+283.2%
2016$525000.00-